Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
Open Access
- 1 April 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 91 (4) , 1753-1760
- https://doi.org/10.1172/jci116385
Abstract
The p53 gene was analyzed in tumor specimens obtained from 52 patients with various types of carcinoma of the thyroid gland by a combined molecular and immunocytochemical approach. The histologic types included 37 well-differentiated papillary and follicular carcinomas, 8 poorly differentiated, and 7 undifferentiated carcinomas. The p53 gene was shown to be unaffected in all differentiated tumors by single-strand conformation polymorphism analysis. However, in two out of eight (25%) of poorly differentiated carcinomas and five out of seven (71%) undifferentiated carcinomas, p53 mutations were identified and subsequently characterized by DNA sequencing. One undifferentiated carcinoma displayed two areas with varying degrees of differentiation. The comparative analysis of the p53 gene, in both the more and the less differentiated area of this tumor, clearly showed that the p53 mutation was confined to the latter component of the tumor specimen. These results indicate that mutations of the p53 gene are associated with the most aggressive histologic types of thyroid tumors, such as the undifferentiated carcinoma and, to a certain extent, the poorly differentiated carcinoma, and that the alterations of this gene represent a late genetic event in human thyroid carcinogenesis.Keywords
This publication has 30 references indexed in Scilit:
- Letters to the editorThe Journal of Pathology, 1992
- Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.1992
- Clonal expansion of p53 mutant cells is associated with brain tumour progressionNature, 1992
- A new Taql polymorphism in the p53 geneNucleic Acids Research, 1992
- Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.1991
- Polymorphism at codon 213 within the p53 gene.1991
- p53 mutations in ovarian cancer: a late event?1991
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Silver Enhancement of Nickel-Diaminobenzidine as Applied to Single and Double Immunoperoxidase StainingBiotechnic & Histochemistry, 1991